scholarly journals Very long-term outcomes after catheter ablation of atrioventricular nodal reentrant tachycardia: How does cryoenergy differ from radiofrequency?

2022 ◽  
Vol 14 (1) ◽  
pp. 85
Author(s):  
C. Chaumont ◽  
A. Mirolo ◽  
A. Savoure ◽  
B. Godin ◽  
N. Auquier ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Reentrant Tachycardia ◽  
Long Term Outcomes

Very long‐term outcomes after catheter ablation of atrioventricular nodal reentrant tachycardia: How does cryoenergy differ from radiofrequency?

2020 ◽  
Vol 31 (12) ◽  
pp. 3215-3222
Author(s):  
Corentin Chaumont ◽  
Adrian Mirolo ◽  
Arnaud Savouré ◽  
Bénédicte Godin ◽  
Nathanaël Auquier ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Reentrant Tachycardia ◽  
Long Term Outcomes

scholarly journals Long-Term Follow-Up After Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in Children

2016 ◽  
Vol 9 (11) ◽  
Author(s):  
David Backhoff ◽  
Sophia Klehs ◽  
Matthias J. Müller ◽  
Heike E. Schneider ◽  
Thomas Kriebel ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Reentrant Tachycardia ◽  
Long Term Follow Up

scholarly journals Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience

2021 ◽  
Vol 8 ◽  
Author(s):  
Hong-Da Zhang ◽  
Lei Ding ◽  
Si-Xian Weng ◽  
Bin Zhou ◽  
Xiao-Tong Ding ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Catheter Ablation ◽  
Left Ventricular ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Supraventricular Arrhythmias ◽  
Reentrant Tachycardia ◽  
Characteristic Analysis ◽  
Free Survival ◽  
Atrioventricular Reentrant Tachycardia

Background: A variety of supraventricular arrhythmias (SVAs) may occur in patients with hypertrophic cardiomyopathy (HCM). The characteristics and long-term ablation outcomes of different types of SVAs in HCM have not been comprehensively investigated.Methods: We retrospectively enrolled 101 consecutive patients with HCM who were referred to the electrophysiology and arrhythmia service from May 2010 to October 2020. The clinical features and ablation outcomes were analyzed.Results: Seventy-eight patients had SVAs, which comprised 50 (64.1%) cases of atrial fibrillation (AF), 16 (20.5%) of atrial flutter (AFL), 15 (19.2%) of atrioventricular reentrant tachycardia (AVRT), 11 (14.1%) of atrial arrhythmia (AT), and 3 (3.8%) of atrioventricular nodal reentrant tachycardia (AVNRT). Thirty-four patients underwent catheter ablation and were followed up for a median (interquartile range) of 58.5 (82.9) months. There was no recurrence in patients with non-AF SVAs. In patients with AF, the 1- and 7-year AF-free survival rates were 87.5 and 49.5%, respectively. A receiver operator characteristic analysis showed that a greater left ventricular end-diastolic dimension (LVEDD) was associated with a higher recurrence of AF, with an optimum cutoff value of 47 mm (c-statistic = 0.91, p = 0.011, sensitivity = 1.00, specificity = 0.82). In Kaplan–Meier analysis, patients with a LVEDD ≥ 47 mm had worse AF-free survival than those with a LVEDD <47 mm (log-rank p = 0.014).Conclusions: In this unique population of HCM, AF was the most common SVA, followed in order by AFL, AVRT, AT, and AVNRT. The long-term catheter ablation outcome for non-AF SVAs in HCM is satisfactory. A greater LVEDD predicts AF recurrence after catheter ablation in patients with HCM.

scholarly journals Diagnosis and treatment of atrioventricular nodal reentrant tachycardia: a case report illustrating clinical management and ablation strategy

2020 ◽  
Vol 4 (4) ◽  
pp. 1-7
Author(s):  
Joris Ector ◽  
Peter Haemers ◽  
Christophe Garweg ◽  
Rik Willems
Keyword(s):  
Catheter Ablation ◽  
Treatment Options ◽  
Three Dimensional ◽  
Good Prognosis ◽  
Slow Pathway ◽  
Supraventricular Arrhythmia ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Reentrant Tachycardia ◽  
European Society Of Cardiology

Abstract Background Atrioventricular nodal reentrant tachycardia (AVNRT) is a common supraventricular arrhythmia that is frequently encountered in an otherwise healthy patient population. Recent guidelines of the European Society of Cardiology underline the role of catheter ablation in the long-term management of these patients. Case summary This case describes the clinical presentation and treatment options in a patient with typical slow/fast AVNRT, the most common subform of AVNRT, where antegrade conduction occurs over the slow pathway and retrograde conduction over the fast pathway. The ablation strategy in these patients is illustrated based on intracardiac recordings in combination with per-procedural three-dimensional imaging. Discussion Atrioventricular nodal reentrant tachycardia is a common arrhythmia with good prognosis but significant impact on quality of life of affected patients. Catheter ablation should be considered early as it can be performed safely and with a very high success rate.

scholarly journals Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience

2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
H D Zhang ◽  
L Ding ◽  
S X Weng ◽  
B Zhou ◽  
X T Ding ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Catheter Ablation ◽  
Left Ventricular ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Supraventricular Arrhythmias ◽  
Reentrant Tachycardia ◽  
Free Survival ◽  
Atrioventricular Reentrant Tachycardia ◽  
Single Center Experience

Abstract Background A variety of supraventricular arrhythmias (SVAs) may occur in patients with hypertrophic cardiomyopathy (HCM). The characteristics and long-term ablation outcomes of different types of SVAs in HCM have not been comprehensively investigated. Methods We retrospectively enrolled 101 consecutive symptomatic HCM patients with suspected arrhythmia from May 2010 to October 2020. The clinical features and ablation outcomes of patients with SVAs were further analyzed. Results Seventy-eight patients had SVAs, consisting of 50 (64.1%) atrial fibrillation (AF), 16 (20.5%) atrial flutter (AFL), 15 (19.2%) atrioventricular reentrant tachycardia (AVRT), 11 (14.1%) atrial arrhythmia (AT), and 3 (3.8%) atrioventricular nodal reentrant tachycardia (AVNRT). Thirty-four patients underwent catheter ablation including 14 for AF, 9 for AVRT, 6 for AFL, 3 for AVNRT, 1 for both AF and AFL, and 1 for both AF and AVRT. They were followed up for a median (interquartile range) of 58.5 (82.9) months. There were no recurrences for patients with non-AF SVAs. For patients with AF, the 1- and 7-year AF-free survival were 87.5% and 49.5%, respectively. A ROC analysis revealed that a greater left ventricular end-diastolic dimension (LVEDD) was associated with higher recurrence of AF with an optimum cutoff value of 47mm (c-statistic = 0.91, p=0.011, sensitivity = 1.00, specificity = 0.82). In Kaplan-Meier analysis, patients with LVEDD ≥47mm had worse AF-free survival (log-rank p=0.014). Conclusions AF is the most common SVA in HCM, with AFL, AVRT, AT, and AVNRT ranking the second to the last according to the prevalence. The long-term catheter ablation outcome for non-AF SVAs in HCM is satisfying. A greater LVEDD predicts AF recurrence after catheter ablation in patients with HCM. FUNDunding Acknowledgement Type of funding sources: Foundation. Main funding source(s): National Natural Science Foundation of China Figure 1 Figure 2

Sign in / Sign up

Export Citation Format

Share Document